Rapt Therapeutics, Inc. (RAPT)

34.06 -0.34 (-0.99%) USD  |  NASDAQ  |  Jan 13, 16:00
32.25 -1.81 (-5.31%) Pre-Market: 08:20
More

Rapt Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Replimune Group, Inc. --
Olema Pharmaceuticals, Inc. --
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --